Company Focus - Isomorphic Labs is leveraging AI to transform drug discovery [1] - The company is expanding its Machine Learning team to enhance its AI models [1] - Isomorphic Labs will present on AI-driven rational drug design at ICML2025 [1] Event Participation - Isomorphic Labs will be present at ICML (July 13-19) [1] - The company encourages attendees to connect with their ML team at ICML [1]

We were thrilled to welcome Nobel laureate and member of our Scientific Advisory Board Venki Ramakrishnan to @IsomorphicLabs in London this week. Our Structural Bioinformatics team leader Adrian Stecula led a riveting fireside chat that explored how diverse perspectives drive innovation and the challenges of identifying true breakthroughs amid technological revolutions. ...

Industry Collaboration & Government Engagement - Isomorphic Labs CTO visited 10 Downing Street for the first OpenBind consortium meeting hosted by the UK government [1] - The OpenBind consortium includes members from industry and academia [1] Project Focus & Goals - OpenBind aims to create a large public dataset of protein-ligand structures and binding affinities for AI in drug discovery [1] - Isomorphic Labs is helping drive the OpenBind project [1]

Event & Recruitment - Isomorphic Labs team will attend ICML in Vancouver, Canada from July 13-19 [1] - Isomorphic Labs is recruiting and seeking talents to join their team [1] Conference Details - ICML2025 is the conference being attended [1] - Registration link for connecting with the team is provided [1]

The establishment of our US presence and the appointment of Dr. Ben Wolf as CMO mark our next chapter as we continue progressing our work to transform drug design and discovery with AI.Read more from Ben here: https://t.co/UNfAVkKnSM https://t.co/NpSIR0CQOx ...

Personnel Change - Isomorphic Labs welcomes Dr Ben Wolf as the new Chief Medical Officer [1] - Dr Wolf brings nearly 20 years of biopharmaceutical experience [1] Strategic Direction - Isomorphic Labs advances therapeutic programs into the clinic using machine learning to transform drug design [1] - Isomorphic Labs establishes a new location in Cambridge, Massachusetts [1]

AI在药物发现领域的应用 - Google DeepMind 和 Isomorphic Labs 正在利用 AI 赋能人类专家，探索广阔的分子空间 [1] - AI 代理被用于药物发现，预示着该领域未来的发展方向 [1]

Company Activities - Isomorphic Labs' President Colin Murdoch will speak at VivaTech 2025 in Paris about AI's potential for drug discovery [1] - Colin Murdoch will participate in an AI Drug Discovery panel discussion on June 12 (2:50 - 3:15 PM CEST) [1] - Colin Murdoch will have a fireside chat on June 13 (10:30 - 10:55 AM CEST) [1] Industry Collaboration - The AI Drug Discovery panel includes NVIDIA's Vice President, Healthcare and Life Sciences [1] - The fireside chat will be with Melissa Hei from the FT (Financial Times) [1]

Read more here:https://t.co/jjijR4h6cg ...

We are thrilled to support the UK’s new #OpenBind consortium, a government-backed initiative to create the world’s largest open dataset for AI drug discovery. ...